Department Pharmacology-Toxicology
Dr. med. Christina I. Hirth
Physician with broad clinical and scientific expertise. Completed her medical studies and earned her doctorate at Charité Berlin. Research experience at the University of Pennsylvania and at Massachusetts General Hospital/Harvard Medical School in biochemistry, biophysics, and radiology. Worked as a research associate in neurology at Charité and held teaching positions in clinical chemistry, pathobiochemistry, neurology, and trauma surgery.
852
Articles
5,803
Sections
460
Images
News from the department of Pharmacology-Toxicology
Latest entry from the department of Pharmacology-Toxicology:
Donanemab
Donanemab Definition Significance: Following the approval of lecanemab as the first anti-amyloid antibody in April 2025 (available in Germany since September 2025), the second anti-amyloid antibody, donanemab, was approved for the drug treatment of Alzheimer's disease (AD) in November 2025. The d...
Go to article